Immunome, Inc. (NASDAQ:IMNM – Free Report) – Investment analysts at Wedbush issued their Q1 2024 earnings per share (EPS) estimates for Immunome in a research note issued on Tuesday, February 6th. Wedbush analyst D. Nierengarten anticipates that the company will post earnings of ($0.24) per share for the quarter. Wedbush currently has a “Outperform” rating […]